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ABSTRACT
Macrophages have been shown to mediate glomer­
ular injury ¡n antiglomeruiar basement membrane 
(anti-GBM) glomerulonephritis in rats and rabbits. 
To evaluate the role of macrophages and the mac­
rophage-related cytokines, colony stimulating fac­
tor-1 (CSF-1), monocyte chemoattractant protein-1 
(MCP-1) and RANTES, accelerated anti-GBM nephritis 
was studied in op/op  mutant mice, which lack CSF-1 
and are severely macrophage deficient, and in het­
erozygous o p /■+■ control mice. Observations were 
m ade 24 h and 3 days after the injection of rabbit 
anti-mouse GBM antibody in mice preimmunized with 
rabbit immunoglobulin G. Proteinuria rose progres­
sively in both groups but did not differ between them 
(urine protein/creatinine ratio at 3 days: 1.01 ±  0.38 in 
op/op  versus 1.45 ±  0.43 in op /+; Ps not significant). In 
both op/op  and o p /+  mice, anti-GBM nephritis was 
associated with renal expression of mRNA for RANTES 
and MCP-1 and barely detectable levels of mRNA for 
CSF-1. In contrast, these cytokines were not expressed 
in sham-injected mice. Morphologic lesions ap­
peared earlier in op/op  mice but were comparable 
by Day 3. Glomerular injury consisted of capillary 
thrombosis and endothelial cell dam age associated 
with mild to moderate leukocyte Infiltration. Despite
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enhanced expression of mRNA for RANTES and MCP-1, 
glomerular macrophage infiltration was not in­
creased in op /+  mice. It was concluded that, in mice, 
in contrast to rats and rabbits, accelerated anti-GBM 
nephritis may develop in the absence of both CSF-1 
and macrophage infiltration.
Key Words: Antiglomeruiar basement membrane nephritis, 
experimental glomerulonephritis, macrophages, colony stim­
ulating factor-1
M acrophages play a key role in mediating glomer­
ular injury in antiglomeruiar basement mem­
brane (anti-GBM) glomerulonephritis in the rabbit 
and rat. The complement-independent autologous 
phase of anti-GBM nephritis in these species is char­
acterized by extensive glomerular macrophage accu­
mulation resulting from an influx of circulating mono­
cytes (1-13). Glomerular macrophages are locally 
activated to elaborate chemotactic peptides, cyto­
kines, proteolytic enzymes, and other inflammatory 
mediators (1,7,9,14). When glomerular macrophage 
infiltration is prevented by monocyte depletion, pro­
teinuria and morphologic injury are ameliorated (2 ,4 -  
6,8,9).
The chemotactic factors responsible for comple­
ment-independent glomerular macrophage influx and 
activation in anti-GBM nephritis are unknown. Sev­
eral monocyte-specific cytokines synthesized by 
mesangial cells are potential candidates, including 
colony stimulating factor (CSF-1), monocyte chemoat­
tractant protein (MCP-1), and RANTES (regulated 
upon activation, normal T cell expressed and secreted) 
(15,16).
In view of the critical role of macrophages in anti- 
GBM nephritis, it was of interest to study this disease 
in the op/op mouse, a mutant strain that lacks CSF-1 
because of a mutation on chromosome 3 within the 
gene coding for CSF-1 (17-19). The absence of CSF-1 
results in severe deficiencies of bone marrow macro­
phages, blood monocytes, tissue macrophages, and 
osteoclasts (17-19). We postulated that the op/op 
mouse would be an ideal model in which to study the 
roles of CSF-1 and of macrophages in mediating glo­
merular injury in anti-GBM nephritis.
METHODS 
Production of Anti-Mouse GBM Antibodies
GBM was prepared from Swiss mouse kidneys (Central 
Institute for the Breeding of Laboratory Animals, TNO, Zeist, 
the Netherlands) by a differential sieving technique, followed
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by sonication and detergent treatment as previously de­
scribed (20). Antisera against this basem ent membrane su s ­
pension were raised in rabbits. The pooled antisera were 
heated at 56°C for 45 min, and the immunoglobulin G (IgG) 
fractions were purified by affinity chromatography on a 
Sepharose 4B-coupled-protein-A column (Pharmacia, Upp­
sala, Sweden). The IgG antibodies were concentrated by 
ultrafiltration with an XM-50 Dialow membrane (Amicon 
Corp., Lexington, MA), sterilized by passage through a sterile
0.2-/u,m-pore-size filter, and stored at -30°C . The IgG con­
centration was measured by the radial immunodiffusion 
technique.
Induction of Anti-GBM Nephritis
Anti-GBM nephritis was induced in 12- to 16-wk old male 
op /+  mice (N  = 10) and o p /o p  mice (N = 10). Animals were 
obtained from an established colony (17,19). Seven days 
before the administration of anti-GBM antibody, the mice 
were preimmunized with 0.2 mg of normal rabbit IgG admin­
istered ip with complete Freund’s adjuvant (1:1 in a total 
volume of 0.2 mL). Nephritis w as then induced by the iv 
injection of rabbit anti-m ouse GBM antibody (0.2 mg in a 
total volume of 0.3 mL). Four nephritic mice in each group 
were euthanized after 24 h, and six additional nephritic mice 
in each group were euthanized at 3 days. Other o p /+  and 
op I op  mice [N = 2 in each group) were preimmunized in an 
identical manner, sham injected with 0-3 mL of NaCL and 
euthanized 3 days later. Additional primmunized o p /4- and 
o p /o p  mice were sham injected with normal rabbit IgG (0.2 
mg in a total volume of 0.3 mL) (JV = 4 in each group). 
Proteinuria did not differ between sham-injected mice given 
saline versus normal rabbit IgG, and these data were com­
bined.
Clinical Parameters
Beginning 7 days before the administration of saline or 
anti-GBM antibody and continuing until the day of euthana­
sia, daily urine specimens were obtained from mice for the 
determination of the urine protein/creatinine ratio (UP/U Cr) 
as an index of urinary protein excretion. Urinary creatinine 
was measured by the Jaffe reaction, and urinary protein was 
measured by the Bio-Rad Protein Assay (Bio-Rad, Richmond, 
CA). Animals were euthanized 24 h or 3 days after iv anti- 
GBM antibody or sham injection. Blood was collected at the 
time of euthanasia for the m easurem ent of BUN, serum  
creatinine, and white blood cell count.
Anti-rabbit IgG antibody activity was determined in mouse 
serum by ELISA (21). M easurements were made in serial 
dilutions in the measurable range and expressed in relative 
absorbance units.
Light Microscopy
Kidneys were harvested, and the right kidney was decap- 
sulated, sectioned in the coronal plane, and fixed in Bouin’s 
solution (Sigma Chemical Co., St. Louis, MO). Fixed kidney 
sections were dehydrated and embedded in paraplast (Ams- 
telstad, Amsterdam, The Netherlands), and 4-/Lm sections 
were stained with hematoxylin and eosin, silver methena- 
mine, and periodic acid-Schiff. The glomerular influx of 
polymorphonuclear leukocytes (PMN) w as determined by 
counting PMN in at least 40 glom eruli/m ouse and was 
expressed as the average number of PMN/glomerulus.
Immunohistology
Kidney fragments were snap frozen in liquid nitrogen, and 
2 - to 4-jicm cryostat sections were incubated with monospe­
cific, fluorescein-labeled goat anti-mouse Ig (heavy and light 
chains) and goat anti-mo use C3 serum (both from Cappel 
Laboratories, West Chester, PA), goat anti-rabbit Ig (Nordic, 
Tilburg, The Netherlands) absorbed with 500 mg/mL of 
lyophilized nonimmune m ouse serum, and rabbit anti-hu­
man ñbrinogen cross-reacting with mouse fibrinogen (Dako, 
Copenhagen, Denmark). The sections were examined in a 
fluorescence microscope equipped with epi-illumination, 
(Leitz, Wetzlar, Germany), and the staining intensity was 
recorded semiquantitatively (grading 0 to 4+) as previously 
described (2 0 ).
The number of glomerular macrophages was determined in 
5-/xm frozen kidney sections with the rat anti-mouse macro­
phage monoclonal F A /11 (22,23) (kindly donated by Dr.
G.L.E. Koch, MRC Laboratory of Molecular Biology, Cam­
bridge, United Kingdom) as the first antibody, a three-step 
avidin-biotin technique with biotinylated goat anti-rat IgG 
(Vector Laboratories, Burlingame, CA) (24) as secondary 
antibodies, and finally, alkaline phosphatase Vectastain ABC 
(Vector Laboratories), The number of macrophages was as­
sessed as the mean number per glomerular cross-section, 
counted in at least 40 glomeruli.
Electron Microscopy
For electron microscopy, small pieces of cortex were fixed 
in 2.5% glutaraldehyde (Sigma), dissolved in 0.1 M sodium 
cacodylate (Sigma) buffer, pH 7.2, for 4 h at 4°C, and washed 
in the same buffer. The tissue fragments were postfixed in 
phosphate-buffered 2% 0 s 0 4 (Johnson Matthey Chem., Roy- 
stone, United Kingdom) for 2 h, dehydrated, and embedded 
in Epon 812 (Merck, Darmstadt, Germany). Ultrathin sec­
tions were cut in an ultratóme (LKP Produkter, Bromma, 
Sweden) and stained with 5% uranyl acetate for 45 min and 
with lead citrate for 2 min at room temperature. The sections 
were examined in an electron microscope (ELMISKOP 101; 
Siemens, Berlin, Germany).
Northern Blot Analysis
mRNA levels of RANTES, CSF-1 , and MCP- 1  were evalu­
ated on Days 1 and 3 in control and nephritic animals. Total 
RNA was extracted from the left kidney, and samples of 10 /¿g 
were then used for northern blot analysis. After electrophore­
sis on a 1% agarose gel, the RNA was transferred to nylon 
filters. Labeling of the cDNA probes specific for CSF-1, 
MCP-1 , RANTES, GAPDH, and 18S ribosomal RNA was 
accomplished by random-prime transcription with [32P]dCTP 
(16,25,26). Nylon filters were prehybridized (65°C, 1 to 3 h) in 
a solution containing 1 M NaCl and 1 % sodium dodecyl 
sulfate and were then hybridized with the labeled cDNA 
probes for 16 h. After the filters were washed to high- 
stringency (0.1X SSPE [150 mM NaCl, 10 mM NaH2P 04, 1 
mM EDTA; pH 7,4] 1% sodium dodecyl sulfate), autoradiog­
raphy with intensifying screens (~70°C) was performed. 
Hybridization of the specific mRNA was quantitated by laser 
densitometry, and results were normalized to the respective 
GAPDH bands. All studies were conducted in accord with the 
NIH Guide for the Care and Use of Laboratory Animals.
Statistical Analysis
Data are expressed as the m ean ± SE. Values were com­
pared with the t  test for paired or unpaired data or analysis of
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variance with Sheffe’s correction. Statistical significance was 
defined as P < 0.05.
sham-injected o p /4- mice were undetectable on Days 
1 and 3.
RESULTS
Clinical Parameters
Body weight was lower in op I  op mice than in o p /4- 
mice at the time of entry into the study (32 ± 2 versus
23 ± 4 g ; P <  0.01). In sham-injected o p } op mice [N  = 
6), the baseline UP/U Cr X  10, calculated as the aver­
age of daily values obtained on 7 days before sham  
injection, was 0.15 ± 0.04. UP/U Cr averaged 0.12 ± 
0.03 over the 3 days after the injection (P, not signif­
icant [NS] versus baseline) (Figure 1). In sham -in­
jected o p /4- mice [N = 6), UP/ U Cr was 0.21 ±  0.05  
during the week before sham injection and 0.23 ±
0.06 after (P, NS versus baseline). At each time before 
and after sham injection, proteinuria was greater in 
o p /4- mice than in op I  op mice (P <  0.05).
Baseline UP/U Cr, calculated as the average of daily 
values obtained on 7 days before the administration of 
rabbit anti-GBM antibody, was again higher in op /  -I- 
thanin op/op  (0.17 ± 0.03 in op /+  versus 0.09 ± 0.02  
in op/op; P < 0.05) (Figure 1). UP/U Cr did not differ 
between the two groups when m easured 24 and 48 h 
after the administration of anti-GBM antibody (Figure
1). At the time of euthanasia on Day 3, UP/ U Cr was
1.01 ± 0.38 in op/op  versus 1.45 ± 0.43 in o p /4-; P, 
NS. In both nephritic groups, proteinuria was signifi­
cantly greater than baseline values (P < 0.001 at 48 
and 72 h, paired t test) and also significantly greater 
than values in the corresponding sham-injected  
groups (P < 0.01 at 48 and 78 h).
Serum creatinine did not differ among the groups at 
the time of euthanasia (data not shown). Serum anti­
rabbit antibody titer, measured 24 h after the admin­
istration of rabbit anti-mouse GBM antibody, was 90 
± 8 in o p /o p  versus 95 ± 7 in o p /4- (P, NS). When 
measured 3 days after the administration of anti-GBM 
antibody, serum anti-rabbit antibody titer was 93 ± 6 
in op /op  versus 215 ± 55 in o p /+  (P <  0,05). Serum  
anti-rabbit antibody titers in sham  injected o p /o p  and
mRNA
Several immune-mediated glomerular diseases 
have been associated with changes in the expression  
of leukocyte-activating cytokines su ch  as CSF-1, 
MCP-1, and RANTES (27-32), We therefore performed 
northern blot analysis on RNA extracted from whole 
kidneys harvested from our experimental animals, As 
shown in Figure 2, sham-injected o p /o p  (N  -  2) and 
op / 4- [N ~ 2) contained no detectable mRNA for 
CSF-1, MCP-1, or RANTES, but had comparable levels 
of mRNA for the constitutionally expressed GAPDH. In 
contrast, kidneys from anti-GBM-injected op /o p  and 
op /  4- mice expressed detectable levels of mRNA for 
RANTES and MCP-1 at 24 and 72 h after the induction  
of glomerulonephritis. Levels for CSF-1 were barely 
detectable. No consistent differences in the expression  
of RANTES or MCP-1 were detectable by inspection or 
densitometry of the northern blots between o p /o p  and 
o p / 4- mice after 24 h (four mice examined per group) 
or after 72 h (six mice examined in each group). In 
fact, mRNA levels for RANTES tended to be higher in 
o p /o p  m ouse kidneys. Thus, anti-GBM nephritis in 
both o p /o p  and op /  4- mice is associated with the renal 
expression of mRNA for RANTES and MCP-1. In con­
trast, neither of these cytokines, nor CSF-1, is ex­
pressed in control, sham-injected mice.
i,
Morphology
Light M icroscopy and Electron M icroscopy. In the
op/op  group, glomerular lesions were absent on Day
1, whereas in the o p /4- group, minor to moderate 
damage could already be observed. These lesions con­
sisted of segmental deposition of hom ogeneous or 
finely granular periodic acid-Schiff-positive material 
in the capillary loops, intravascular coagulation, en­
dothelial cell damage, and necrosis. At Day 3, glomer­
ular damage was now more extensive and identical in 
both groups (Figure 3). At this time, occasional epi-
Urinary Protein/ 
Creatinine Ratio
(mg/ml/mg/dl)
Hours
Figure l. Proteinuria in sham-injected and anti-GBM antibody-injected op/4- and op/op mice.
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thelial cell hypertrophy could also be seen. Sham- 
injected op/op  and o p /+  mice did not show any 
glomerular lesions.
The glomerular neutrophil infiltrationin o p /o p  mice 
was 0.5 ± 0.3 PMN/glomerular cross-section on Day 1 
and increased to 1.7 ± 0.9 PMN/ glomerular cross- 
section on Day 3. Although neutrophil infiltration in  
op /+  mice was greater on Day 1 than on Day 3, the 
intragroup variation was very large (1-9 ± 3 versus 0.7  
± 0.4 PMN/ glomerular cross-section). Glomerular 
PMN accumulated predominantly in necrotic areas* 
Glomerular neutrophilic infiltration in sham-injected 
op/op  and op / + mice was low and comparable (0.2 ± 
0.0 versus 0.2 ± 0 . 1  PMN/glomerular cross-section, 
respectively). The glomerular lesions, especially the 
deposition of fibrin and endothelial cell damage, were 
confirmed at the electron microscopic level (Figure 4).
Immunohistology. All kidneys showed strong linear 
staining of the GBM for rabbit and m ouse IgG (3-F) 
(Figure 5A and B). Fibrin deposits varied but paral­
leled roughly the segm ental necrotic lesions seen by  
light microscopy (Figure 5D). C3 deposits were also 
variable (Figure 5C). In addition to minor mesangial 
deposits in all glomeruli, which is a normal finding in 
mice, more extensive C3 deposits could be observed 
along the glomerular capillary wall in a fine granular 
pattern and in the m esangial areas of several kidneys. 
Sham-Injected mice of both strains showed only occa­
sional minor C3 and Ig deposits in the mesangium.
Macrophages were barely detectable in the glomer­
uli of sham-injected op/op  mice (0.01 ± 0 .0 2 /glom er­
ular cross-section; N ~  2) and in op/op  mice 3 days
Figure 3. Light microscopy of the glomerular damage in an 
op/op mouse 3 days after the injection of rabbit anti-mouse 
GBM antibody, identical lesions were present in op/+ mice. 
Extensive intravascular coagulation (arrowheads) accom­
panied by swelling and necrosis of endothelial cells can be 
seen. A few polymorphonuclear granulocytes (arrow) are 
located in a capillary loop (original magnification, X770).
after the induction of nephritis (0.06 ± 0 .0 3 /glomer­
ular cross-section; N  = 5). In op /+  mice, the number 
of glomerular macrophages at Day 3 was higher than 
in op/op  mice (0.68 ± 0.51 / glomerular cross-section; 
JV = 4) but did not exceed the number in normal mice 
(0.8 to 1.0 macrophages/glomerular cross-section; 
unpublished observation).
DISCUSSION
There is considerable evidence that glomerular in­
jury in the autologous phase of anti-GBM nephritis in 
the rat and rabbit is mediated by infiltrating glomer­
ular macrophages (1-13). In accelerated models of 
anti-GBM nephritis, macrophage infiltration of the 
glomerulus begins within 24 h after antibody admin­
istration and peaks within 2 to 3 days (3,6,8,11,12). 
The macrophage dependence of autologous-phase glo­
merular injury in rat and rabbit models has been 
demonstrated by experimental maneuvers that in­
duce monocytopenia (2,4-6,8,9). These maneuvers 
reduce glomerular macrophage infiltration and ame­
liorate or prevent proteinuria and histologic abnor­
malities in the rat and rabbit (2,4-6,8,9).
The op/op  mouse carries a mutation on chromo­
some 3 within the gene coding for CSF-1 (17-19). As a 
result, the serum of op/op mice lacks CSF-1 (18). 
Normally, CSF-1 regulates the survival and prolifera­
tion of mononoclear phagocytes and is responsible for 
normal macrophage and osteoclast maturation (17—
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Figure 4. Electron photomicrograph of a glomerular capillary loop of an op/+ mouse 1 day after the administration of rabbit 
anti-mouse GBM antibody. Two polymorphononuclear granulocytes partly adhere to the inner side of the denuded GBM, 
replacing and destroying the endothelial cells. The foot processes of the visceral epithelial cell show signs of fusion (original 
magnification, x 15,000). Abbreviations; Epi, visceral epithelial cell; End, endothelial cell.
19). The absence of CSF-1 results In severe deficien­
cies of bone marrow macrophages, blood monocytes» 
tissue macrophages, and osteoclasts (17-19). Kidney 
tissue macrophages in op/op mice are reduced to 3% 
of the numbers present in op/ - h mice at 2 m onths of 
age and to 28% of the numbers present in op / + mice 
at 3 months of age (19). We postulated that the op/op  
mouse would be an ideal model in which to study the 
roles of CSF-1 and of macrophages in mediating glo­
merular injury in anti-GBM nephritis.
Glomerular injury in our model of accelerated au­
tologous-phase anti-GBM nephritis occurred in op/op  
mice, despite the absence of CSF-1 and the absence of 
glomerular macrophage infiltration, Moreover, glo­
merular injury in control op/ + mice also occurred in 
the absence of glomerular macrophage accunxulation. 
These observations suggest that glomerular injury in 
the early autologous phase of murine anti-GBM ne­
phritis does not require CSF-1 or macrophage infiltra­
tion. However, we cannot exclude the possibility that
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Figure 5. Immunofluorescence findings after the injection of rabbit anti-mouse GBM antibody in op/+ mice. Similar results were 
found in op/op mice. (A) Linear binding of rabbit Ig to the GBM. (B) Identical binding of mouse Ig. (C) Fine granular deposits 
of C3 along the capillary wall with additional deposition in the mesangium, (D) Massive segmental deposits of fibrin mainly in 
the capillary lumina (original magnification, x510).
the few macrophages present in the glomerulus, acti­
vated by the up-regulated glomerular chemokines, 
may have played a role In mediating renal injury.
Mouse anti-rabbit antibody titer was significantly 
higher at Day 3 in op / +  mice injected with rabbit 
anti-rat GBM antibody than in similarly treated op /op  
mice. The finding of similar intensity of immunofluo­
rescence staining for m ouse Ig in the glomeruli of 
op/ - f- and op/op  mice, despite increased serum anti­
rabbit antibodies in op/ +  mice, may be explained if 
glomerular binding sites for anti-rabbit antibody were 
saturated in both strains of mice during the autolo­
gous phase. Impaired antibody response in op fop  
mice is not surprising, in view of the important role 
macrophages play in antigen processing and presen­
tation. Although the increased antibody response in 
op /  + mice was associated with earlier morphologic 
injury, by Day 3, the severity of glomerular injury was 
comparable in both groups of mice.
Monocyte-specific cytokines synthesized by me-
sangial cells, such as CSF-1, MCP-1, and RANTES, 
have been shown to play a role in mediating glomer­
ular injury in several experimental models of renal 
disease, including anti-GBM nephritis (28-32). How­
ever, in our studies, glomerular injury developed in 
CSF-1-deficient op/op  mice. Moreover, macrophage 
infiltration did not increase in nephritic op /+  mice, 
despite enhanced renal expression of mRNA for the 
potent monocyte chemo attract ants MCP-1 and RAN­
TES. Because we did not localize the source of the 
increased mRNA to glomeruli versus tubules, our 
observations do not necessarily reflect a dissociation 
between monocyte chemoattractant expression and 
biologic response. In addition, it is possible that an 
enhanced message for these cytokines was not trans­
lated into increased protein product.
We conclude that, in contrast to the mechanisms 
operative in the rat and rabbit, glomerular injury in 
the autologous phase of anti-GBM nephritis can occur
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in the mouse in the absence of glomerular macro­
phage infiltration and in the absence of CSF-1.
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